|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Brueckl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Stenzinger, Albrecht; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2021):
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
In: Translational Lung Cancer Research, Bd. 10, Nr. 7: S. 3093-3106
Illini, Oliver; Hochmair, Maximilian Johannes; Fabikan, Hannah; Weinlinger, Christoph; Tufman, Amanda; Swalduz, Aurelie; Lamberg, Kristina; Hashemi, Sayed M. S.; Huemer, Florian; Vikstrom, Anders; Wermke, Martin; Absenger, Gudrun; Addeo, Alfredo; Banerji, Shantanu; Calles, Antonio; Clarke, Stephen; Di Maio, Massimo; Durand, Alice; Duruisseaux, Michael; Itchins, Malinda; Kaaranien, Okko-Sakari; Krenn, Florian; Laack, Eckart; de Langen, Adrianus Johannes; Mohorcic, Katja; Pall, Georg; Passaro, Antonio; Prager, Gerald; Rittmeyer, Achim; Rothenstein, Jeffrey; Schumacher, Michael; Woell, Ewald und Valipour, Arschang
(2021):
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211019675
Tufman, Amanda; Neumann, Jens; Manapov, Farkhad; Sellmer, Laura; Jung, Andreas; Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Mertsch, Pontus; Borgmeier, Astrid; Semrau, Sabine; Rittmeyer, Achim; Ulm, Bernhard; Ulm, Kurt; Flentje, Michael; Fietkau, Rainer und Huber, Rudolf Maria
(2021):
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
In: Lung Cancer, Bd. 160: S. 17-27
Brückl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2020):
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
In: Clinical Medicine Insights-Oncology, Bd. 14: S. 1-9
[PDF, 433kB]
Gütz, Sylvia; Tufman, Amanda; Pawel, Joachim von; Rittmeyer, Achim; Borgmeier, Astrid; Ferre, Pierre; Edlich, Birgit und Huber, Rudolf Maria
(2017):
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
In: Oncotargets and therapy, Bd. 10: S. 1081-1089
[PDF, 679kB]
Heigener, David Felix; Höffken, Gert; Würflein, Dieter; Feurer, Matthias; Rittmeyer, Achim; Huber, Roland Maria; Pietsch, Markus; Ring, Arne und Deppermann, Karl-Matthias
(2017):
Chemotherapie beim älteren Patienten mit nicht kleinzelligem Lungenkarzinom: Eine nicht-interventionelle, prospektive, multizentrische Beobachtungsstudie.
In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 4, E21-E27